EUR/USD
1.16692
-0.151%
Gold
4222.49
-2.392%
Oil
57.096
0.322%
USD/JPY
150.480
0.034%
GBP/USD
1.34355
0.007%
GBP/JPY
202.181
0.047%
Real-time News
On October 18th, Tesla (TSLA.O) announced on social media that its proxy advisor, Institutional Shareholder Services (ISS), has recommended against a compensation package previously voted on by shareholders twice (to which Musk has already received it), as well as a 2025 CEO performance-based bonus (which Musk will not receive unless shareholders achieve significant gains). ISSs unfounded and absurd opposition to Iras proposals clearly demonstrates their disconnect from reality. As Teslas longest-serving independent director, Ira established a governance framework that resulted in an astonishing 39,000% increase in Teslas Total Shareholder Return (TSR) during his tenure. He embodies our highly engaged board—hands-on leadership, effective governance, and a focus on long-term value. When ISS has no vested interest, it can easily tell others how to vote. Please support Tesla and vote for all proposals.Boeing (BA.N): Willing to accept the mediators request to return to the negotiating table (labor and management related to the military industry).Tesla (TSLA.O): Calls for votes consistent with the companys position on all resolutions.On October 18, ECB board member Wensch said that the ECB should not react to small deviations from the 2% inflation target, especially when these fluctuations are due to factors that are difficult for monetary policy to intervene. Wensch said: "I will not be nervous when inflation deviates from the target by 10, 20, or 30 basis points." With the deposit rate at 2% and price increases around 2%, officials basically expressed satisfaction with the current policy. But the ECB still expects inflation to be below target next year, which has sparked speculation among some about whether further easing is needed. Wensch said that the expected decline may not be as significant as initially expected. In addition, the slowdown in inflation is the result of a "positive supply shock" - energy inflation is falling. In Wenschs view, "the possibility of further interest rate cuts is decreasing, but if there are some downward surprises in the coming months, this possibility may reappear."On October 18, the Financial Times reported that the government led by British Prime Minister Starmer believes that it is about to reach a major drug pricing agreement with the White House, under which the UK will pay billions of pounds more for some drugs in exchange for the US imposing "as low as zero" tariffs on British drug exports. British officials said that the negotiations have entered an advanced stage. They said that the ultimate goal will be to impose zero tariffs on all drugs produced in the UK. Some people familiar with the negotiations said that the United States may push for a 10% tariff. Varun Chandra, chief business adviser to British Prime Minister Starmer, has been leading the negotiations. A London official said: "We are quite close to reaching an agreement. Extensive discussions have been held in the past 10 days."
